Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs... Show more
a provider of medical devices for critical care, urology and surgery
Industry PharmaceuticalsOther
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| EMXC | 106.49 | 0.74 | +0.70% |
| iShares MSCI Emerging Mkts ex China ETF | |||
| GSEE | 73.33 | 0.44 | +0.61% |
| Goldman Sachs MarketBeta Emer Mkt Eq ETF | |||
| LAPR | 25.36 | 0.02 | +0.08% |
| Innovator Premium Inc 15 Bffr ETF - Aprl | |||
| STEN | 27.46 | -0.06 | -0.21% |
| iShares Large Cap 10% Trgt Buffr Sep ETF | |||
| ARKF | 39.43 | -0.60 | -1.50% |
| ARK Blockchain & Fintech Innovation ETF | |||
A.I.dvisor indicates that over the last year, TFX has been loosely correlated with A. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if TFX jumps, then A could also see price increases.
| Ticker / NAME | Correlation To TFX | 1D Price Change % | ||
|---|---|---|---|---|
| TFX | 100% | -4.20% | ||
| A - TFX | 51% Loosely correlated | -0.45% | ||
| RVTY - TFX | 47% Loosely correlated | -0.96% | ||
| TNDM - TFX | 44% Loosely correlated | -6.27% | ||
| SNN - TFX | 42% Loosely correlated | -2.29% | ||
| MTD - TFX | 42% Loosely correlated | +1.68% | ||
More | ||||
| Ticker / NAME | Correlation To TFX | 1D Price Change % |
|---|---|---|
| TFX | 100% | -4.20% |
| Pharmaceuticals: Other industry (55 stocks) | 49% Loosely correlated | +0.16% |
| Pharmaceuticals industry (159 stocks) | 39% Loosely correlated | +0.69% |
TFX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 48 cases where TFX's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TFX advanced for three days, in of 293 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 194 cases where TFX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Momentum Indicator moved below the 0 level on June 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on TFX as a result. In of 79 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for TFX turned negative on June 11, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at .
TFX moved below its 50-day moving average on June 16, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for TFX crossed bearishly below the 50-day moving average on June 22, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TFX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. TFX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.746) is normal, around the industry mean (4.511). TFX's P/E Ratio (2027.833) is considerably higher than the industry average of (182.659). Projected Growth (PEG Ratio) (0.165) is also within normal values, averaging (3.431). Dividend Yield (0.011) settles around the average of (0.025) among similar stocks. P/S Ratio (2.535) is also within normal values, averaging (76.815).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TFX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 97, placing this stock worse than average.